The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

ADDICTION TO GLUTETHIMIDE (DORIDEN)

Published Online:https://doi.org/10.1176/ajp.115.6.551

This report illustrates one case where a potent, new, non-barbiturate sedative (glutethimide) proved to be addicting to a predisposed alcoholic with an underlying schizophrenic illness. It emphasizes, however, the danger of addiction that this drug possesses, which in this patient was greater than alcohol, barbiturates, or any of the tranquilizing medications.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.